查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830916

2025年全球创伤性脑损伤生物标记市场报告

Traumatic Brain Injury Biomarkers Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，创伤性脑损伤生物标记市场发展迅速，预计将从2024年的11.3亿美元成长到2025年的13.8亿美元，复合年增长率达22.1%。预测期内的成长主要归因于道路交通事故发生率上升、人们对脑部健康的认识提高、急诊就诊量增加、军事相关创伤性脑损伤病例数量增加以及诊断方法的不断扩展。

预计未来几年，创伤性脑损伤生物标记市场将呈指数级增长，到2029年市场规模将达到30.3亿美元，复合年增长率（CAGR）为21.7%。预测期内的成长主要归因于对快速诊断工具需求的不断增长、神经学研究投入的增加、个人化医疗的日益普及、脑损伤生物标记临床试验的扩展以及医疗保健支出的增加。预测期内的关键趋势包括蛋白质体学平台的进步、基于血液的生物标记检测技术的创新、携带式诊断设备的开发、神经发炎标记物的研究以及人工智慧在生物标记分析中的应用。

创伤性脑损伤（TBI）生物标记是存在于血液、脑脊髓液和脑组织中的可测量的生物学指标，包括蛋白质、酵素和遗传物质，它们能够指示脑损伤的发生和严重程度。这些生物标记用于检测、诊断和监测TBI，从而深入了解损伤程度并指导治疗决策。

创伤性脑损伤（TBI）生物标记主要分为蛋白质生物标记、遗传生物标记和代谢组生物标记三大类。蛋白质生物标记是指脑组织损伤后释放到血液或脑脊髓液中的特定蛋白质，其检测可用于评估损伤的存在、严重程度和进展。生物标记可从血液、脑脊髓液、尿液和其他样本中提取，用于诊断、预后和治疗监测。主要最终用户包括医院、诊所、诊断实验室和研究机构。

2025年，美国关税的突然上调及其引发的贸易摩擦对製药公司造成了严重衝击。利润丰厚的学名药生产商尤其脆弱，一些公司不得不缩减低利润药物的生产规模。生物技术公司也因关税导致的专用试剂短缺而面临临床试验延期。为因应这一局面，製药业正在印度和欧洲扩大原料药的生产，增加库存，并游说政府对基本药物给予贸易豁免。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，提供创伤性脑损伤生物标记市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势以及商业机会，为创伤性脑损伤生物标誌物行业提供成功所需的关键数据。本市场研究报告对行业现状和未来发展趋势进行了深入分析，为您提供全面的观点。

预计未来几年，道路交通事故数量的增加将推动创伤性脑损伤生物标记市场的成长。道路交通事故是造成人身伤害和财产损失的突发事件，通常需要即时医疗干预。此类事故的增加主要是由于都市化和机动化进程导致私家车使用量增加。创伤性脑损伤生物标记能够快速且准确地评估头部损伤，从而为这类情况下的救治提供支持。透过检测血液中的特定蛋白质，这些生物标记能够帮助临床医生在急救现场及时做出治疗决策，改善患者的预后。例如，根据欧盟委员会2024年5月发布的道路安全报告，欧盟道路交通事故死亡总数预计将在2022年达到20,634人，高于2021年的19,917人。因此，道路交通事故数量的增加正在推动创伤性脑损伤生物标记市场的发展。

个人化医疗的日益普及预计也将推动创伤性脑损伤生物标记市场的成长。个人化医疗根据患者的遗传、环境和生活方式因素量身定制治疗方案，以优化治疗效果和预后。基因组技术的进步使得精准识别基因突变和进行标靶治疗成为可能，因此对这种治疗方式的需求不断增长。创伤性脑损伤生物标记透过识别与脑损伤相关的特定生物学指标，为个人化医疗做出贡献。这些技术有助于根据患者的独特反应制定个人化治疗方案，从而改善復健效果并优化临床决策。例如，美国非营利组织个人化医疗联盟（PMC）于2024年2月报告称，2023年美国食品药物管理局（FDA）核准的新个人化药物数量从2022年的12种增加到26种。因此，个人化医疗的日益普及正在推动创伤性脑损伤生物标记市场的发展。

创伤性脑损伤生物标记市场的主要企业正在开发创新解决方案，例如基于实验室的血液检测，以提高脑震盪诊断的速度和准确性。基于实验室的血液检测透过测量血液中的特定生物标记来评估脑损伤的存在和严重程度，从而实现更快、更客观的临床决策。例如，总部位于美国的医疗保健公司雅培实验室于2025年6月推出了Alinity i和Architect i1000SR实验室检测。这些检测测量两种关键生物标记：胶质纤维酸性蛋白（GFAP）和泛素羧基末端水解酶（UCH）-L1，以帮助临床医生在受伤后12小时内评估疑似脑震盪。这些检测仅需18分钟即可得出结果，支持在紧急现场快速进行分诊，并减少不必要的CT扫描。这项技术创新为医生提供了一种可靠的工具来识别潜在的创伤性脑损伤患者，标誌着急诊在提供快速、循证护理方面取得了重大进展。

创伤性脑损伤生物标记市场由提供生物标记检验研究、临床试验支援、神经学数据分析、基于生物标记的筛检计画和法规咨询等服务的营业单位所获得的收入构成。市场价值包括服务供应商销售的或包含在其服务产品中的相关产品的价值。创伤性脑损伤生物标记市场还包括生物标记检测套件、实验室晶片设备、神经影像相关生物标记、生物感测器整合检测系统和多重诊断平台的销售。此市场价值为“出厂价”，即产品製造商或创建者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的产品价值。该市场中的产品价值还包括产品创建者销售的任何相关服务的价值。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球创伤性脑损伤生物标记：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球创伤性脑损伤生物标记市场：成长率分析
  • 全球创伤性脑损伤生物标记市场表现：规模与成长，2019-2024年
  • 全球创伤性脑损伤生物标记市场预测：规模和成长，2024-2029年，2034年
  • 全球创伤性脑损伤生物标记：潜在市场规模 (TAM)

第六章 市场细分

  • 全球创伤性脑损伤生物标记市场按类型、表现和预测划分，2019-2024年、2024-2029年、2034年
  • 蛋白质生物标记
  • 基因生物标记
  • 代谢组学生物标誌物
  • 全球创伤性脑损伤生物标记市场按样本类型、表现和预测划分，2019-2024年、2024-2029年、2034年
  • 血
  • 脑脊髓液（CSF）
  • 尿
  • 全球创伤性脑损伤生物标记市场：按应用、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 诊断
  • 预后
  • 监测治疗效果
  • 全球创伤性脑损伤生物标记市场按最终用途、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 医院和诊所
  • 诊断实验室
  • 研究所
  • 全球创伤性脑损伤生物标记市场：蛋白质生物标记细分、按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 胶质纤维酸性蛋白（GFAP）
  • 泛素C端水解酵素L1（UCH-L1）
  • S100钙结合蛋白质B（S100B）
  • 神经元特异性烯醇化酶（NSE）
  • 全球创伤性脑损伤生物标记市场：基因生物标记细分、类型、表现和预测（2019-2024年、2024-2029年、2034年）
  • 载脂蛋白E (APOE) 基因分型
  • 脑源性神经营养因子（BDNF）多态性
  • 白细胞介素-6 (IL-6) 基因突变
  • 肿瘤坏死因子α（TNF-α）多态性
  • 全球创伤性脑损伤生物标记市场：代谢组学生物标记细分、按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 乳酸
  • 肌酸
  • 柯林
  • N-乙酰天门冬胺酸（NAA）

第七章 区域和国家分析

  • 全球创伤性脑损伤生物标记市场：按地区、表现和预测划分，2019-2024年、2024-2029年、2034年
  • 全球创伤性脑损伤生物标记市场：国家、表现与预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 创伤性脑损伤生物标记市场：竞争格局
  • 创伤性脑损伤生物标记市场：公司概况
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • BioMerieux SA
  • DiaSorin SpA
  • Abcam Limited
  • Fujirebio Inc.
  • Meso Scale Diagnostics（MSD）
  • Olink Holding AB
  • Quanterix Corporation
  • OriGene Technologies Inc.
  • BioDirection Inc.
  • NanoDx Inc.
  • BrainScope Company Inc.
  • BrainBox Solutions Inc.
  • DiaGenic ASA
  • NeuroTrauma Sciences LLC
  • Banyan Biomarkers Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年创伤性脑损伤生物标记市场：提供新机会的国家
  • 2029年创伤性脑损伤生物标记市场：充满新机会的细分市场
  • 2029年创伤性脑损伤生物标记市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r37909

Traumatic brain injury (TBI) biomarkers are measurable biological indicators, including proteins, enzymes, or genetic material, present in blood, cerebrospinal fluid, or brain tissue that indicate the occurrence and severity of brain injury. These biomarkers are used to detect, diagnose, and monitor TBI, providing insights into injury extent and informing treatment decisions.

The primary categories of TBI biomarkers include protein biomarkers, genetic biomarkers, and metabolomic biomarkers. Protein biomarkers are specific proteins released into blood or cerebrospinal fluid due to brain tissue damage and can be measured to evaluate the presence, severity, and progression of the injury. Biomarkers can be collected from samples such as blood, cerebrospinal fluid (CSF), and urine, and are applied in diagnosis, prognosis, and monitoring treatment response. Key end users include hospitals and clinics, diagnostic laboratories, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The traumatic brain injury biomarkers market research report is one of a series of new reports from The Business Research Company that provides traumatic brain injury biomarkers market statistics, including the traumatic brain injury biomarkers industry global market size, regional shares, competitors with the traumatic brain injury biomarkers market share, detailed traumatic brain injury biomarkers market segments, market trends, and opportunities, and any further data you may need to thrive in the traumatic brain injury biomarkers industry. This traumatic brain injury biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The traumatic brain injury biomarkers market size has grown exponentially in recent years. It will grow from $1.13 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 22.1%. The growth in the historic period can be attributed to the rising incidence of road traffic accidents, increasing awareness of brain health, growth in emergency room visits, an increase in military-related traumatic brain injury cases, and the expansion of diagnostic options.

The traumatic brain injury biomarkers market size is expected to see exponential growth in the next few years. It will grow to $3.03 billion in 2029 at a compound annual growth rate (CAGR) of 21.7%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic tools, growing investments in neurological research, rising adoption of personalized medicine, expansion of clinical trials for brain injury biomarkers, and higher healthcare expenditure. Major trends in the forecast period include advancements in proteomic platforms, innovations in blood-based biomarker detection, development of portable diagnostic devices, research in neuroinflammation markers, and the integration of artificial intelligence in biomarker analysis.

The rising number of road traffic accidents is expected to drive growth in the traumatic brain injury biomarkers market in the coming years. Road traffic accidents are unplanned events that cause injury, harm, or damage, often necessitating immediate medical intervention. The increase in such accidents is largely due to higher private vehicle usage associated with urbanization and motorization. Traumatic brain injury biomarkers support care in these situations by enabling rapid and accurate assessment of head injuries. By detecting specific proteins in the blood, these biomarkers allow clinicians to make timely treatment decisions, improving patient outcomes in emergency settings. For example, according to a May 2024 report on road safety by the European Commission, the total number of road fatalities in the EU reached 20,634 in 2022, up from 19,917 in 2021. Therefore, the growing number of road traffic accidents is fueling the market for traumatic brain injury biomarkers.

The increasing adoption of personalized medicine is also expected to support growth in the traumatic brain injury biomarkers market. Personalized medicine involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize care and outcomes. The demand for this approach is rising due to advancements in genomic technologies, which allow precise identification of genetic variations and enable targeted therapies. Traumatic brain injury biomarkers contribute to personalized medicine by identifying specific biological indicators associated with brain injuries. They help design individualized treatment plans based on a patient's unique response, enhancing recovery outcomes and optimizing clinical decision-making. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, up from 12 in 2022. Hence, the growing adoption of personalized medicine is driving the market for traumatic brain injury biomarkers.

Key players in the traumatic brain injury biomarkers market are developing innovative solutions, such as lab-based blood tests, to enhance the speed and accuracy of concussion diagnosis. A lab-based blood test measures specific biomarkers in the blood to assess the presence and severity of brain injuries, enabling earlier and more objective clinical decisions. For example, in June 2025, Abbott Laboratories, a US-based healthcare company, launched the Alinity i and Architect i1000SR lab tests. These tests measure two key biomarkers glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase (UCH)-L1 to help clinicians evaluate suspected concussions within 12 hours of injury. The tests deliver results in just 18 minutes, supporting faster triage decisions in emergency settings and reducing the need for unnecessary CT scans. This innovation provides physicians with a reliable tool for identifying patients with potential traumatic brain injuries and represents a major advancement in providing rapid, evidence-based care in emergency departments.

Major players in the traumatic brain injury biomarkers market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Biogen Inc., BioMerieux S.A., DiaSorin S.p.A., Abcam Limited, Fujirebio Inc., Meso Scale Diagnostics (MSD), Olink Holding AB, Quanterix Corporation, OriGene Technologies Inc., BioDirection Inc., NanoDx Inc., BrainScope Company Inc., BrainBox Solutions Inc., DiaGenic ASA, NeuroTrauma Sciences LLC, and Banyan Biomarkers Inc.

North America was the largest region in the traumatic brain injury biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in traumatic brain injury biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the traumatic brain injury biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The traumatic brain injury biomarkers market consists of revenues earned by entities by providing services such as biomarker validation studies, clinical trial support, neurological data analysis, biomarker-based screening programs, and regulatory consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The traumatic brain injury biomarkers market also includes sales of biomarker assay kits, lab-on-a-chip devices, neuroimaging-linked biomarkers, biosensor-integrated test systems, and multiplex diagnostic platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Traumatic Brain Injury Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on traumatic brain injury biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for traumatic brain injury biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The traumatic brain injury biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Protein Biomarkers; Genetic Biomarkers; Metabolomic Biomarkers
  • 2) By Sample Type: Blood-based; Cerebrospinal Fluid (CSF)-Based; Urine-Based
  • 3) By Application: Diagnosis; Prognosis; Monitoring Treatment Response
  • 4) By End Use: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes
  • Subsegments:
  • 1) By Protein Biomarkers: Glial Fibrillary Acidic Protein (GFAP); Ubiquitin C-Terminal Hydrolase L1 (UCH-L1); S100 Calcium Binding Protein B (S100B); Neuron-Specific Enolase (NSE)
  • 2) By Genetic Biomarkers: Apolipoprotein E (APOE) Genotyping; Brain-Derived Neurotrophic Factor (BDNF) Polymorphism; Interleukin-6 (IL-6) Gene Variants; Tumor Necrosis Factor-Alpha (TNF-a) Polymorphism
  • 3) By Metabolomic Biomarkers: Lactate; Creatine; Choline; N-Acetylaspartate (NAA)
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Biogen Inc.; BioMerieux S.A.; DiaSorin S.p.A.; Abcam Limited; Fujirebio Inc.; Meso Scale Diagnostics (MSD); Olink Holding AB; Quanterix Corporation; OriGene Technologies Inc.; BioDirection Inc.; NanoDx Inc.; BrainScope Company Inc.; BrainBox Solutions Inc.; DiaGenic ASA; NeuroTrauma Sciences LLC; Banyan Biomarkers Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Traumatic Brain Injury Biomarkers Market Characteristics

3. Traumatic Brain Injury Biomarkers Market Trends And Strategies

4. Traumatic Brain Injury Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Traumatic Brain Injury Biomarkers Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Traumatic Brain Injury Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Traumatic Brain Injury Biomarkers Market Growth Rate Analysis
  • 5.4. Global Traumatic Brain Injury Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Traumatic Brain Injury Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Traumatic Brain Injury Biomarkers Total Addressable Market (TAM)

6. Traumatic Brain Injury Biomarkers Market Segmentation

  • 6.1. Global Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Protein Biomarkers
  • Genetic Biomarkers
  • Metabolomic Biomarkers
  • 6.2. Global Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood-based
  • Cerebrospinal Fluid (CSF)-Based
  • Urine-Based
  • 6.3. Global Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnosis
  • Prognosis
  • Monitoring Treatment Response
  • 6.4. Global Traumatic Brain Injury Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • 6.5. Global Traumatic Brain Injury Biomarkers Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glial Fibrillary Acidic Protein (GFAP)
  • Ubiquitin C-Terminal Hydrolase L1 (UCH-L1)
  • S100 Calcium Binding Protein B (S100B)
  • Neuron-Specific Enolase (NSE)
  • 6.6. Global Traumatic Brain Injury Biomarkers Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Apolipoprotein E (APOE) Genotyping
  • Brain-Derived Neurotrophic Factor (BDNF) Polymorphism
  • Interleukin-6 (IL-6) Gene Variants
  • Tumor Necrosis Factor-Alpha (TNF-伪) Polymorphism
  • 6.7. Global Traumatic Brain Injury Biomarkers Market, Sub-Segmentation Of Metabolomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lactate
  • Creatine
  • Choline
  • N-Acetylaspartate (NAA)

7. Traumatic Brain Injury Biomarkers Market Regional And Country Analysis

  • 7.1. Global Traumatic Brain Injury Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Traumatic Brain Injury Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Traumatic Brain Injury Biomarkers Market

  • 8.1. Asia-Pacific Traumatic Brain Injury Biomarkers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Traumatic Brain Injury Biomarkers Market

  • 9.1. China Traumatic Brain Injury Biomarkers Market Overview
  • 9.2. China Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Traumatic Brain Injury Biomarkers Market

  • 10.1. India Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Traumatic Brain Injury Biomarkers Market

  • 11.1. Japan Traumatic Brain Injury Biomarkers Market Overview
  • 11.2. Japan Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Traumatic Brain Injury Biomarkers Market

  • 12.1. Australia Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Traumatic Brain Injury Biomarkers Market

  • 13.1. Indonesia Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Traumatic Brain Injury Biomarkers Market

  • 14.1. South Korea Traumatic Brain Injury Biomarkers Market Overview
  • 14.2. South Korea Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Traumatic Brain Injury Biomarkers Market

  • 15.1. Western Europe Traumatic Brain Injury Biomarkers Market Overview
  • 15.2. Western Europe Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Traumatic Brain Injury Biomarkers Market

  • 16.1. UK Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Traumatic Brain Injury Biomarkers Market

  • 17.1. Germany Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Traumatic Brain Injury Biomarkers Market

  • 18.1. France Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Traumatic Brain Injury Biomarkers Market

  • 19.1. Italy Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Traumatic Brain Injury Biomarkers Market

  • 20.1. Spain Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Traumatic Brain Injury Biomarkers Market

  • 21.1. Eastern Europe Traumatic Brain Injury Biomarkers Market Overview
  • 21.2. Eastern Europe Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Traumatic Brain Injury Biomarkers Market

  • 22.1. Russia Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Traumatic Brain Injury Biomarkers Market

  • 23.1. North America Traumatic Brain Injury Biomarkers Market Overview
  • 23.2. North America Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Traumatic Brain Injury Biomarkers Market

  • 24.1. USA Traumatic Brain Injury Biomarkers Market Overview
  • 24.2. USA Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Traumatic Brain Injury Biomarkers Market

  • 25.1. Canada Traumatic Brain Injury Biomarkers Market Overview
  • 25.2. Canada Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Traumatic Brain Injury Biomarkers Market

  • 26.1. South America Traumatic Brain Injury Biomarkers Market Overview
  • 26.2. South America Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Traumatic Brain Injury Biomarkers Market

  • 27.1. Brazil Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Traumatic Brain Injury Biomarkers Market

  • 28.1. Middle East Traumatic Brain Injury Biomarkers Market Overview
  • 28.2. Middle East Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Traumatic Brain Injury Biomarkers Market

  • 29.1. Africa Traumatic Brain Injury Biomarkers Market Overview
  • 29.2. Africa Traumatic Brain Injury Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Traumatic Brain Injury Biomarkers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Traumatic Brain Injury Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Traumatic Brain Injury Biomarkers Market Competitive Landscape And Company Profiles

  • 30.1. Traumatic Brain Injury Biomarkers Market Competitive Landscape
  • 30.2. Traumatic Brain Injury Biomarkers Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Traumatic Brain Injury Biomarkers Market Other Major And Innovative Companies

  • 31.1. BioMerieux S.A.
  • 31.2. DiaSorin S.p.A.
  • 31.3. Abcam Limited
  • 31.4. Fujirebio Inc.
  • 31.5. Meso Scale Diagnostics (MSD)
  • 31.6. Olink Holding AB
  • 31.7. Quanterix Corporation
  • 31.8. OriGene Technologies Inc.
  • 31.9. BioDirection Inc.
  • 31.10. NanoDx Inc.
  • 31.11. BrainScope Company Inc.
  • 31.12. BrainBox Solutions Inc.
  • 31.13. DiaGenic ASA
  • 31.14. NeuroTrauma Sciences LLC
  • 31.15. Banyan Biomarkers Inc.

32. Global Traumatic Brain Injury Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Traumatic Brain Injury Biomarkers Market

34. Recent Developments In The Traumatic Brain Injury Biomarkers Market

35. Traumatic Brain Injury Biomarkers Market High Potential Countries, Segments and Strategies

  • 35.1 Traumatic Brain Injury Biomarkers Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Traumatic Brain Injury Biomarkers Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Traumatic Brain Injury Biomarkers Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer